(Q73635050)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9274891%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

title

The prevention of early postmenopausal bone loss by cyclical etidronate therapy: a 2-year, double-blind, placebo-controlled study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9274891%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

R J Herd

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9274891%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

R Balena

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9274891%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

G M Blake

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9274891%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

P J Ryan

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9274891%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

I Fogelman

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9274891%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

publication date

1 August 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9274891%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Medicine

5 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9274891%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

103

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9274891%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9274891%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

92-99

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9274891%20AND%20SRC:MED&resulttype=core&format=json

The role of bisphosphonates in the prevention and treatment of osteoporosis

5 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900019-3

Bisphosphonates in the treatment of metabolic bone diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900019-3

Combined therapy with estrogen and etidronate has an additive effect on bone mineral density in the hip and vertebrae: four-year randomized study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900019-3

Prevention of postmenopausal bone loss by tiludronate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900019-3

Bone density at various sites for prediction of hip fractures. The Study of Osteoporotic Fractures Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900019-3

Baseline measurement of bone mass predicts fracture in white women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900019-3

Long-term fracture prediction by bone mineral assessed at different skeletal sites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900019-3

Age and bone mass as predictors of fracture in a prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900019-3

Bone densitometry in clinical practice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900019-3

Bisphosphonates and vertebral fracture: An epidemiological perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900019-3

Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900019-3

Postmenopausal screening for osteopenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900019-3

Future prospects for hormone replacement therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900019-3

Estrogen therapy for postmenopausal symptoms and prevention of osteoporosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900019-3

Estrogen replacement therapy in older women. Comparisons between Alzheimer's disease cases and nondemented control subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900019-3

Hormone replacement therapy and risk of breast cancer: results from epidemiologic studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900019-3

Hormone-replacement therapy--breast versus heart versus bone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900019-3

Effect of cyclical therapy with phosphorus and etidronate on axial bone mineral density in postmenopausal osteoporotic women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900019-3

Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900019-3

Rates of change in bone mineral density of the spine, heel, femoral neck and radius in healthy postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900019-3

Effect of menopause on femoral and vertebral bone loss

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900019-3

Pamidronate: an unrecognized problem in gastrointestinal tolerability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900019-3

Esophagitis associated with the use of alendronate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900019-3

"Pill esophagitis"--the case of alendronate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900019-3

10.1016/S0002-9343(97)00019-3

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9274891%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference